Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
NCT07257484Phase 4Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Weill Cornell Medicine. Started Jun 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07257484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257484.